Is There a Generic Mounjaro (Tirzepatide) in India? Patent Status and Real Alternatives 

Introduction

Mounjaro (tirzepatide) is increasingly being used to help manage type 2 diabetes and support weight loss in eligible adults. Because it can be costly and may not always be easy to obtain, many people are looking for cheaper versions. This has raised common questions about whether a generic version is available in India and whether other medicines work in the same way. 

Mounjaro is the brand name for the medicine tirzepatide. Tirzepatide helps control blood sugar by acting on natural gut hormones that help regulate blood sugar and appetite¹. Understanding the difference between a brand name and its generic name can help patients ask clearer questions when discussing treatment options with their doctor. 

Is There a Generic Mounjaro in India?

Mounjaro is the brand name for tirzepatide, a medicine used to improve blood sugar control in adults with type 2 diabetes and to support weight management in eligible adults. It works on two hormone pathways, involving GIP and GLP-1, which help regulate blood sugar, appetite, and how full a person feels after eating. At present, there is no approved generic version of Mounjaro available in India^2,3.

Mounjaro remains a branded medicine. Generic availability may be delayed because patents and regulatory protections can give the original manufacturer rights over the medicine for a period of time before other companies can market approved generic versions⁴.

Patent Status of Mounjaro (Tirzepatide) in India

Mounjaro (tirzepatide) has patent and regulatory protections that can affect when generic versions may become available. In simple terms, these protections may prevent other companies from selling competing generic versions for a period of time. Studies of GLP-1 medicines show that patents and regulatory protections can delay the availability of generic alternatives^4,5.

Patent records show that applications related to tirzepatide and Mounjaro have been filed and granted in India, with Indian Patent Office decisions recorded in 2025 for Eli Lilly and Company, and these protections are valid until the year 2036. These patent protections are one factor that may affect when approved generic tirzepatide products can enter the Indian market⁶.

What Are the Current Alternatives to Generic Mounjaro?

If Mounjaro is not suitable, available, or affordable, your doctor may discuss other medicines from the same broader group of treatment options, based on your health needs. 

Possible alternatives to discuss with your doctor include: 

• Semaglutide: Semaglutide is used with diet and exercise to improve blood sugar control in adults with type 2 diabetes. It is also used for long-term weight management in certain adults with obesity or overweight. It helps the body release insulin when blood sugar is high, reduces the amount of sugar made by the liver, slows the movement of food through the stomach, and can reduce appetite^7,8.
• Liraglutide: Liraglutide helps adults with type 2 diabetes improve blood sugar control when used with healthy eating and regular physical activity. It is also used in some people as part of long-term weight management. Liraglutide can help lower the amount of sugar made by the liver, slow digestion, reduce appetite, and increase insulin release when blood sugar is high^7,9.

Note: These medicines are alternatives to Mounjaro, not generic versions of Mounjaro. They contain different active ingredients and may not have the same effects for every person. 

Can You Switch from Mounjaro to Another Medication?

Yes, it may be possible to switch from Mounjaro to another medicine, but this should only be done under your doctor’s guidance. Studies suggest that changing from one GLP-1-based medicine to another may require careful dose adjustment and follow-up to support safety and effectiveness¹⁰. Your doctor will decide whether switching is suitable based on your health condition, treatment goals, side effects, and how well your current treatment is working. 

Possible side effects during or after switching from Mounjaro to another medicine include¹⁰: 

• Nausea 
• Diarrhoea 
• Constipation 
• Vomiting 
• Gallbladder inflammation 
• Low blood sugar, especially if used with insulin or certain diabetes tablets. 

How to Avoid Fake Generic Mounjaro

To reduce the risk of using a fake product claiming to be “generic Mounjaro,” consider the following precautions¹¹:

• Check the medicine and its packaging before use. Do not use it if the packaging, label, spelling, colour, or device looks unusual. 
• Look for the batch number and expiry date and follow any safety alerts issued by health authorities. 
• Do not use the medicine if you think it may be fake or if the pen or device does not work properly. 
• Contact your pharmacist or doctor if you suspect the medicine is fake or have concerns about its quality. 
• Remember that fake medicines may contain the wrong ingredient, the wrong dose, or no active medicine at all. Their quality, safety, and effectiveness cannot be guaranteed. 

Conclusion

Mounjaro (tirzepatide) can help manage type 2 diabetes and support weight loss in eligible adults, but there is currently no approved generic version available in India. If cost, availability, or side effects are a concern, speak with your doctor about other approved treatments that may be suitable for you. Always get medicines from trusted, licensed sources, and avoid products claiming to be “generic Mounjaro” unless they are approved by the appropriate health authorities. Choosing treatment with medical guidance is the safest way to get the most benefit while reducing avoidable risks. 

Also Read: Generic GLP-1 Medications: Availability, Costs & Affordable Alternatives

Frequently Asked Questions (FAQs)

References

1. Baker DE, Walley K, Levien TL. Tirzepatide. Hosp Pharm. 2023;58(3):227-243. doi:10.1177/00185787221125724. Available from: https://pubmed.ncbi.nlm.nih.gov/37216078/

2. Farzam K, Patel P. Tirzepatide. In: StatPearls. StatPearls Publishing; 2026. Accessed August 5, 2026. Available from: http://www.ncbi.nlm.nih.gov/books/NBK585056/ 

3. Mounjaro: Uses, Dosage, Side Effects & Warnings. Drugs.com. Accessed August 5, 2026. Available from: https://www.drugs.com/mounjaro.html 

4. Generic Mounjaro Availability & Release Date. Drugs.com. Accessed August 5, 2026. Available from: https://www.drugs.com/availability/generic-mounjaro.html 

5. Alhiary R, Kesselheim AS, Gabriele S, Beall RF, Tu SS, Feldman WB. Patents and Regulatory Exclusivities on GLP-1 Receptor Agonists. JAMA. 2023;330(7):650-657. doi:10.1001/jama.2023.13872. Available from: https://pmc.ncbi.nlm.nih.gov/articles/PMC11457043/

6. Patent Opposition Database. Accessed August 5, 2026. Available from: https://www.patentoppositions.org/en/drugs/tirzepatide-mounjaro-zepbound-and-yurpeak/patent_office_decisions/691adef5d2708f0005081ad7 

7. GLP-1 medicines for weight loss and diabetes: what you need to know. GOV.UK. Accessed August 5, 2026. Available from: https://www.gov.uk/government/publications/glp-1-medicines-for-weight-loss-and-diabetes-what-you-need-to-know/glp-1-medicines-for-weight-loss-and-diabetes-what-you-need-to-know 

8. Semaglutide Injection: MedlinePlus Drug Information. Accessed August 5, 2026. Available from: https://medlineplus.gov/druginfo/meds/a618008.html 

9. Liraglutide Injection: MedlinePlus Drug Information. Accessed August 5, 2026. Available from: https://medlineplus.gov/druginfo/meds/a611003.html 

10. Barakat S, Ramdeen S, Khaimova R. Safety and Efficacy of Switching Patients With Type 2 Diabetes From Glucagon-Like Peptide-1 Receptor Agonists to Tirzepatide: A Case Series. Hosp Pharm. 2024;59(6):614-619. doi:10.1177/00185787241266803. Available from: https://pmc.ncbi.nlm.nih.gov/articles/PMC11497530/

11. Fake Mounjaro (tirzepatide) KwikPen 15mg pre-filled pens. GOV.UK. Accessed August 5, 2026. Available from: https://www.gov.uk/government/news/fake-mounjaro-tirzepatide-kwikpen-15mg-pre-filled-pens 

Disclaimer: The information provided here is for educational/awareness purposes only and is not intended to be a substitute for medical treatment by a healthcare professional and should not be relied upon to diagnose or treat any medical condition. The reader should consult a registered medical practitioner to determine the appropriateness of the information and before consuming any medication. PharmEasy does not provide any guarantee or warranty (express or implied) regarding the accuracy, adequacy, completeness, legality, reliability or usefulness of the information; and disclaims any liability arising thereof.

Links and product recommendations in the information provided here are advertisements of third-party products available on the website. PharmEasy does not make any representation on the accuracy or suitability of such products/services. Advertisements do not influence the editorial decisions or content. The information in this blog is subject to change without notice. The authors and administrators reserve the right to modify, add, or remove content without notification. It is your responsibility to review this disclaimer regularly for any changes.